Form 4 Filing for Jennifer E. Cook

This filing details stock transactions made by Jennifer E. Cook, a director at BridgeBio Pharma, Inc. On June 15, 2026, Cook acquired 65,921 shares at $8.45 each and 17,167 shares at $16.75 each. Concurrently, Cook disposed of 88,737 shares at a weighted average price between $66.10 and $67.095, and 1,503 shares at a weighted average price between $67.10 and $67.20. The filing also notes the exercise of stock options, with 65,921 options exercised at $0.00 (conversion price $8.45) and 17,167 options exercised at $0.00 (conversion price $16.75), resulting in post-transaction holdings of 39,000 and 34,334 shares respectively. These transactions were executed under a Rule 10b5-1 sales plan. The filing includes a power of attorney authorizing specific individuals to act on Cook's behalf for SEC filings.